We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Hepatitis B Virus Genotype B and High Expression of Interferon Alpha Receptor β Subunit are Associated With Better Response to Pegylated Interferon Alpha 2a in Chinese Patients With Chronic Hepatitis B Infection.
- Authors
He-Bin Fan; Ya-Bin Guo; You-Fu Zhu; An-Shen Chen; Mu-Xiu Zhou; Zhi Li; Li-Tong Xu; Xiao-Ju Ma; Fu-Ming Yan
- Abstract
Background: Hepatitis B virus (HBV) is one of leading causes of various hepatic diseases including acute and chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Hundreds of million people worldwide are infected by HBV, chronically. Objectives: This study in conducted to investigate the influence of Hepatitis B virus (HBV) genotypes and type I IFN-α receptor β subunit (IFNAR2) expression in liver on response to treatment with pegylated IFN-α-2a (Peg-IFN-α-2a) for chronic hepatitis B infection. Patients and Methods: In this study, 65 eligible patients with chronic hepatitis B disease were enrolled. HBV genotypes of these patients were analyzed by using PCR-RFLP of the surface gene of HBV. The expression of IFNAR2 in the liver was immune histochemically investigated using anti-IFNAR2 antibody. All immune histochemical slides were read semiquantitatively by image analysis. Chronic hepatitis B patients were treated with Peg-IFN-α-2a therapy for a 48-week period and followed up for 24 weeks. Baseline characteristics and sustained viral response (SVR) to Peg-IFN-α-2a therapy were evaluated. Results: 55 % of patients exhibited HBV genotype B and 31.7 % patients exhibited HBV genotypes C infections. After treatment with Peg-IFN-α-2a, SVR was achieved in 66.7 % of patients with HBV genotype B and in 26.3 % of patients with HBV genotype C (P = 0.009). Semiquantitative and the image analysis indicated by gray level values revealed a higher IFNAR2 expression in the group with severe inflammation (P < 0.001). Patients' high IFNAR2 protein expression had a significant impact on SVR to Peg-IFN-α-2a therapy (P = 0.028). Conclusions: HBV genotype B and high expression of IFNAR2 in the liver of chronic hepatitis B patients are closely associated with better response to Peg-IFN-α-2a therapy in chronic hepatitis B disease.
- Subjects
CHI-squared test; CHINESE people; GENES; INTERFERONS; RESEARCH methodology; T-test (Statistics); DATA analysis software; CHRONIC hepatitis B
- Publication
Hepatitis Monthly, 2012, Vol 12, Issue 5, p96
- ISSN
1735-143X
- Publication type
Article
- DOI
10.5812/hepatmon.6173